GlaxoSmithKline PLC Director/PDMR Shareholding (1418U)
27 July 2015 - 6:07PM
UK Regulatory
TIDMGSK
RNS Number : 1418U
GlaxoSmithKline PLC
27 July 2015
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons
Discharging
Managerial Responsibilities or Connected Persons
The Administrators of the GlaxoSmithKline 2009 Performance Share
Plan (the Plan) notified the Company and the under-mentioned
Directors, Persons Discharging Managerial Responsibilities ('PDMR')
and Connected Persons on 24 July 2015 of the following increases in
their notional interests in Ordinary Shares at a price of 1369.00
pence per Ordinary Share and American Depositary Shares ('ADSs') at
a price of $41.80 per ADS following the notional re-investment of
the dividend paid to shareholders on 9 July 2015.
Director/PDMR Ordinary ADSs
Shares
------------------- ---------- ---------
Sir Andrew Witty 18997.185
------------------- ---------- ---------
Dr M M Slaoui 5596.705
------------------- ---------- ---------
Mr S Dingemans 8251.600
------------------- ---------- ---------
Mr R G Connor 3700.161
------------------- ---------- ---------
Mr N Hirons 592.901 205.521
------------------- ---------- ---------
Mr S A Hussain 7756.471
------------------- ---------- ---------
Mr W C Louv 1641.746
------------------- ---------- ---------
Mr D S Redfern 2813.799
------------------- ---------- ---------
Ms C Thomas 3910.257
------------------- ---------- ---------
Mr P C Thomson 1996.718
------------------- ---------- ---------
Mr D E Troy 3481.744
------------------- ---------- ---------
Dr P J T Vallance 8326.341
------------------- ---------- ---------
Ms E Walmsley 4816.457
------------------- ---------- ---------
Mrs V A Whyte 524.954
------------------- ---------- ---------
Connected Person Ordinary ADSs
Shares
---------------------------- ---------------- ------------
Dr K Slaoui (Connected
Person to Dr M M Slaoui) 90.534
---------------------------- ---------------- ------------
Mrs K Thomson (Connected
Person to Mr P C Thomson) 49.550
---------------------------- ---------------- ------------
The notional dividends accrued will be paid out in proportion to
the percentage of participants' Plan holdings that vest following
the end of the relevant measurement period.
This notification relates to transactions notified in accordance
with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).
V A Whyte
Company Secretary
27 July 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSVDLBLEDFBBBQ
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024